Authors: Mouridsen, H Gershanovich, M Sun, Y Perez-Carrion, R Boni, C Monnier, A Apffelstaedt, J Smith, R Sleeboom, HP Janicke, F Pluzanska, A Dank, M Becquart, D Bapsy, PP Salminen, E Snyder, R Lassus, M Verbeek, JA Staffler, B Chaudri-Ross, HA Dugan, M

Citation: H. Mouridsen et al., Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the international letrozole breast cancer group, J CL ONCOL, 19(10), 2001, pp. 2596-2606

Authors: Freue, M Kjaer, M Boni, C Joliver, J Janicke, F Willemse, PHB Coombes, RC Van Belle, S Perez-Carrion, R Zieschang, J de Palacios, PI Rose, C

Citation: M. Freue et al., Open comparative trial of formestane versus megestrol acetate in postmenopausal patients with advanced breast cancer previously treated with tamoxifen, BREAST, 9(1), 2000, pp. 9-16

Authors: Vorobiof, DA Kleeberg, UR Perez-Carrion, R Dodwell, DJ Robertson, JFR Calvo, L Dowsett, M Clack, G

Citation: Da. Vorobiof et al., A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex (R)) with intramuscular formestane in postmenopausal women with advanced breast cancer, ANN ONCOL, 10(10), 1999, pp. 1219-1225